Table 2.

Summarization of neurological status and details pertaining to COVID-19 symptomatology and behavior of suspected or confirmed COVID-19 cohort

	Child (n = 11) (%)	Adult (n = 3) (%)	Total (n = 14) (%)
1. Symptomatology related to COVID-19
(a) Fever	100	100	100
(b) Others
I. Sore throat	90.9	66.7	85.7
II. Dry cough	45.5	100	57.1
III. Dyspnea	0	0	0
IV. Pain abdomen	9.1	0	7.1
V. Diarrhea	27.3	33.3	28.6
VI. Loss of smell	36.4	100	50.0
VII. Loss of taste	18.2	100	35.7
VIII. Headache	27.3	100	42.9
IX. Red eyes	0	0	0
X. Myalgia	81.8	100	88.9
XI. Skin rashes	0	0	0
2. Involvement of family members	63.6	66.7	64.4
3. History of contact with COVID-19 patients	63.6	100	71.4
4. Travel history	0	66.7	14.3
5. Hospitalization	9.1	0	7.1
6. Residence in containment zone	100	100	100
7. Co-morbidities
(a) Hypertension	0	66.7	14.3
(b) Type II Diabetes Mellitus	0	33.3	7.1
(c) Hypothyroidism	0	0	0
(d) Renal dysfunction	0	0	0
(e) Cardiac dysfunction	0	0	0
(f) Liver dysfunction	0	0	0
(g) Hematological dysfunction	9.1	0	7.1
8. Neurological symptom (worsening or new onset)
(a) Fixed motor weakness	9.1	0	7.1
(b) Seizure	18.2	0	14.3
(c) Headache	9.1	33.3	14.3
(d) Transient ischemic attack	45.5	0	35.7
(e) Cognitive and behavioral symptoms	0	0	0
(f) Visual symptoms	0	0	0
(g) Extra-pyamidal symptoms	0	0	0

n: Number